Literature DB >> 24568624

Perspectives on tissue-engineered nerve regeneration for the treatment of spinal cord injury.

Moon Suk Kim1, Hai Bang Lee.   

Abstract

Over the past few decades, substantial progress has been made to safely improve nerve function in spinal cord injury (SCI) patients through the regeneration of injured nerve tissue. This perspective focuses on an extensive overview of SCI research as well as tissue-engineered nerve regeneration for the treatment of SCI.

Entities:  

Mesh:

Year:  2014        PMID: 24568624      PMCID: PMC4085818          DOI: 10.1089/ten.tea.2014.0094

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  23 in total

Review 1.  Acute spinal cord injury: pharmacotherapy and drug development perspectives.

Authors:  A R Blight; M P Zimber
Journal:  Curr Opin Investig Drugs       Date:  2001-06

Review 2.  Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.

Authors:  Joyce Doorn; Guido Moll; Katarina Le Blanc; Clemens van Blitterswijk; Jan de Boer
Journal:  Tissue Eng Part B Rev       Date:  2011-12-22       Impact factor: 6.389

3.  Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.

Authors:  Satoshi Nori; Yohei Okada; Akimasa Yasuda; Osahiko Tsuji; Yuichiro Takahashi; Yoshiomi Kobayashi; Kanehiro Fujiyoshi; Masato Koike; Yasuo Uchiyama; Eiji Ikeda; Yoshiaki Toyama; Shinya Yamanaka; Masaya Nakamura; Hideyuki Okano
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 4.  Acute pain mechanisms.

Authors:  L S Sorkin; M S Wallace
Journal:  Surg Clin North Am       Date:  1999-04       Impact factor: 2.741

Review 5.  Rehabilitation for the neurologic patient.

Authors:  Natasha Olby; Krista B Halling; Teresa R Glick
Journal:  Vet Clin North Am Small Anim Pract       Date:  2005-11       Impact factor: 2.093

6.  Regeneration of completely transected spinal cord using scaffold of poly(D,L-lactide-co-glycolide)/small intestinal submucosa seeded with rat bone marrow stem cells.

Authors:  Kkot Nim Kang; Ju Young Lee; Da Yeon Kim; Bit Na Lee; Hyun Hee Ahn; Bong Lee; Gilson Khang; So Ra Park; Byoung Hyun Min; Jae Ho Kim; Hai Bang Lee; Moon Suk Kim
Journal:  Tissue Eng Part A       Date:  2011-06-14       Impact factor: 3.845

7.  Autonomic dysreflexia: incidence in persons with neurologically complete and incomplete tetraplegia.

Authors:  Wendy M Helkowski; John F Ditunno; Michael Boninger
Journal:  J Spinal Cord Med       Date:  2003       Impact factor: 1.985

8.  Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies.

Authors:  L F Geffner; P Santacruz; M Izurieta; L Flor; B Maldonado; A H Auad; X Montenegro; R Gonzalez; F Silva
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 9.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

Authors:  Arnold I Caplan
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 10.  Clinical translation of human neural stem cells.

Authors:  Ann Tsukamoto; Nobuko Uchida; Alexandra Capela; Thorsten Gorba; Stephen Huhn
Journal:  Stem Cell Res Ther       Date:  2013-08-29       Impact factor: 6.832

View more
  1 in total

1.  A partition-type tubular scaffold loaded with PDGF-releasing microspheres for spinal cord repair facilitates the directional migration and growth of cells.

Authors:  Xue Chen; Mei-Ling Xu; Cheng-Niu Wang; Lu-Zhong Zhang; Ya-Hong Zhao; Chang-Lai Zhu; Ying Chen; Jian Wu; Yu-Min Yang; Xiao-Dong Wang
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.